Nitinol Drug Eluting Surfaces for Coronary Stents

Nowadays, drug eluting stents (DES) are the treatment of choice for de novo atherosclerotic lesions. Novel DES are shifting to polymer-free (PF) drug delivery in order to avoid the problem of late stent thrombosis associated with long term polymer presence in the vessel lumen. The scope of this study was to assess the potential of a microporous...